Virbac SA
PAR:VIRP

Watchlist Manager

Virbac SA

PAR:VIRP

Watchlist

Dividends

Discount Rate

Price: 334.5 EUR -0.74% Market Closed

Market Cap: 2.8B EUR

Have any thoughts about
Virbac SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 334.5 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

VIRP Alert

Virbac SA

334.5

-2.5 (-0.74%)

52 Week Range	275.5 400
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Virbac SA

What unique competitive advantages
does Virbac SA hold over its rivals?

What risks and challenges
does Virbac SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Virbac SA.

What unique competitive advantages
does Virbac SA hold over its rivals?

What risks and challenges
does Virbac SA face in the near future?

Has there been any significant insider trading activity
in Virbac SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Virbac SA.

Provide P/S
for Virbac SA.

Provide P/E
for Virbac SA.

Provide P/OCF
for Virbac SA.

Provide P/FCFE
for Virbac SA.

Provide P/B
for Virbac SA.

Provide EV/S
for Virbac SA.

Provide EV/GP
for Virbac SA.

Provide EV/EBITDA
for Virbac SA.

Provide EV/EBIT
for Virbac SA.

Provide EV/OCF
for Virbac SA.

Provide EV/FCFF
for Virbac SA.

Provide EV/IC
for Virbac SA.

Show me price targets
for Virbac SA made by professional analysts.

What are the Revenue projections
for Virbac SA?

How accurate were the past Revenue estimates
for Virbac SA?

What are the Net Income projections
for Virbac SA?

How accurate were the past Net Income estimates
for Virbac SA?

What are the EPS projections
for Virbac SA?

How accurate were the past EPS estimates
for Virbac SA?

What are the EBIT projections
for Virbac SA?

How accurate were the past EBIT estimates
for Virbac SA?

Compare the revenue forecasts
for Virbac SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Virbac SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Virbac SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Virbac SA compared to its peers.

Compare the P/E ratios
of Virbac SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Virbac SA with its peers.

Analyze the financial leverage
of Virbac SA compared to its main competitors.

Show all profitability ratios
for Virbac SA.

Provide ROE
for Virbac SA.

Provide ROA
for Virbac SA.

Provide ROIC
for Virbac SA.

Provide ROCE
for Virbac SA.

Provide Gross Margin
for Virbac SA.

Provide Operating Margin
for Virbac SA.

Provide Net Margin
for Virbac SA.

Provide FCF Margin
for Virbac SA.

Show all solvency ratios
for Virbac SA.

Provide D/E Ratio
for Virbac SA.

Provide D/A Ratio
for Virbac SA.

Provide Interest Coverage Ratio
for Virbac SA.

Provide Altman Z-Score Ratio
for Virbac SA.

Provide Quick Ratio
for Virbac SA.

Provide Current Ratio
for Virbac SA.

Provide Cash Ratio
for Virbac SA.

What is the historical Revenue growth
over the last 5 years for Virbac SA?

What is the historical Net Income growth
over the last 5 years for Virbac SA?

What is the current Free Cash Flow
of Virbac SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Virbac SA.

P/S
Price to Sales

2.1

Current

2.2

Median

2.6

Industry

Lower than median

Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

2.1

Market Cap

2.8B EUR

Revenue

1.3B EUR

All Countries

Forward Multiples

			Market Cap	P/S
FR		Virbac SA PAR:VIRP	2.8B EUR	2.1
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	4 211 733
US		Eli Lilly and Co NYSE:LLY	746.8B USD	18.3
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	578.3
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	12.3
US		Johnson & Johnson NYSE:JNJ	365.6B USD	4.2
US		Merck & Co Inc NYSE:MRK	249.1B USD	3.9
CH		Roche Holding AG SIX:ROG	208.6B CHF	3.6
CH		Novartis AG SIX:NOVN	181.4B CHF	4.2
UK		AstraZeneca PLC LSE:AZN	159.6B GBP	4.1
IE	E	Endo International PLC LSE:0Y5F	146B USD	63

				Revenue Growth
FR		Virbac SA PAR:VIRP	Average P/S: 382 947.9 2.1	28%
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	4 211 733	22%
US		Eli Lilly and Co NYSE:LLY	18.3	110%
UK		Dechra Pharmaceuticals PLC LSE:DPH	578.3	29%
DK		Novo Nordisk A/S CSE:NOVO B	12.3	77%
US		Johnson & Johnson NYSE:JNJ	4.2	12%
US		Merck & Co Inc NYSE:MRK	3.9	20%
CH		Roche Holding AG SIX:ROG	3.6	15%
CH		Novartis AG SIX:NOVN	4.2	17%
UK		AstraZeneca PLC LSE:AZN	4.1	35%
IE	E	Endo International PLC LSE:0Y5F	63	N/A

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

2-Years Forward

P/S

1.9

3-Years Forward

P/S

1.7

Virbac SA
PAR:VIRP

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Virbac SA PAR:VIRP

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Virbac SA
PAR:VIRP

P/S
Price to Sales